XML 31 R17.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Note 9 - Variable Interest Entities | 12 Months Ended
--- | ---
Mar. 31, 2017
Notes to Financial Statements |
Variable Interest Entity Disclosure [Text Block] |
9. | VARIABLE INTEREST ENTITIES
A variable interest entity ("VIE") is an entity that either (i) has insufficient equity to permit the entity to finance its activities without additional subordinated financial support, or (ii) has equity investors who lack the characteristics of a controlling financial interest. Under ASC 810 - Consolidation , an entity that holds a variable interest in a VIE and meets certain requirements would be considered to be the primary beneficiary of the VIE and required to consolidate the VIE in its consolidated financial statements. In order to be considered the primary beneficiary of a VIE, an entity must hold a variable interest in the VIE and have both:
| ● | the power to direct the activities that most significantly impact the economic performance of the VIE; and
| ● | the right to receive benefits from, or the obligation to absorb losses of, the VIE that could be potentially significant to the VIE.
As described in Note 8 , the Company acquired Delphax Series B Preferred Stock, loaned funds to Delphax, and acquired the Warrant. In accordance with ASC 810, the Company evaluated whether Delphax was a VIE as of November 24, 2015. Based principally on the fact that the Company granted Delphax subordinated financial support, the Company determined that Delphax was a VIE on that date. Therefore, it was necessary for the Company to assess whether it held any “variable interests”, as defined in ASC 810, in Delphax. The Company concluded that its investments in Delphax’s equity and debt, and its investment in the Warrant, each constituted a variable interest. Based on its determination that it held variable interests in a VIE, the Company was required to assess whether it was Delphax’s “primary beneficiary”, as defined in ASC 810. After considering all relevant facts and circumstances, the Company concluded that it became the primary beneficiary of Delphax on November 24, 2015. While various factors informed the Company ’s determination, the Company assigned considerable weight to both 1 ) the shortness of time until June 1, 2016 when the Company would become entitled to elect four -sevenths of the members of the board of directors of Delphax and 2 ) the anticipated financial significance of Delphax’s activities in the periods subsequent to June 1, 2016. Since the Company became Delphax’s primary beneficiary on November 24, 2015, the Company consolidated Delphax in its consolidated financial statements beginning on that date. Refer to Note 8 for the fair value of the assets and liabilities of Delphax on the acquisition date. The following table sets forth the carrying values of Delphax ’s assets and liabilities as of March 31, 2017 and 2016:
|  | March 31, 2017 |  |  | March 31, 2016 |
ASSETS |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 328,327 |  |  | $ | 249,528 |
Accounts receivable, net |  |  | 2,036,221 |  |  |  | 1,433,494 |
Inventories, net |  |  | 1,941,729 |  |  |  | 4,642,298 |
Other current assets |  |  | 1,145,274 |  |  |  | 1,034,067 |
Total current assets |  |  | 5,451,551 |  |  |  | 7,359,387 |
Property and equipment, net |  |  | 8,007 |  |  |  | 625,684 |
Intangible assets, net |  |  | - |  |  |  | 1,109,112 |
Goodwill |  |  | - |  |  |  | 275,408 |
Other assets |  |  | - |  |  |  | 26,020 |
Total assets |  | $ | 5,459,558 |  |  | $ | 9,395,611 |
LIABILITIES |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 2,482,578 |  |  | $ | 1,684,802 |
Income tax payable |  |  | 11,312 |  |  |  | 11,312 |
Accrued expenses |  |  | 3,627,162 |  |  |  | 1,926,340 |
Short-term debt |  |  | 4,714,257 |  |  |  | 4,435,572 |
Total current liabilities |  |  | 10,835,309 |  |  |  | 8,058,026 |
Long-term debt |  |  | - |  |  |  | 4,835 |
Other long-term liabilities |  |  | - |  |  |  | 606,358 |
Total liabilities |  | $ | 10,835,309 |  |  | $ | 8,669,219 |
Net assets |  | $ | (5,375,751 | ) |  | $ | 726,392 |
The short-term debt include amounts due from Delphax to Air T, Inc. Those amounts have been eliminated in consolidation. As of March 31, 2017, the outstanding principal amount of the Senior Subordinated Note was approximately $2,889,000 ( $2,576,000 as of March 31, 2016) and the outstanding borrowings under the Delphax Senior Credit Agreement was $1,873,000. Short-term debt as reflected in the above table includes approximately $388,000 and $76,000 of accrued interest, due to the Company from Delphax Canada under the Senior Subordinated Note for the fiscal year 2017 and 2016 respectively. Short-term debt also includes approximately $112,000, due to the Company from Delphax Canada under the Delphax Senior Credit Agreement for the fiscal year 2017. The assets of Delphax can only be used to satisfy the obligations of Delphax. Furthermore, Delphax ’s creditors do not have recourse to the assets of Air T, Inc. or its subsidiaries. Delphax ’s revenues and expenses are included in our consolidated financial statements beginning November 24, 2015 through March 31, 2017. Revenues and expenses prior to the date of initial consolidation are excluded. The following table sets forth the revenue and expenses of Delphax that are included in the Company ’s consolidated statements of income (loss) and comprehensive income (loss) for the years ended March 31, 2017 and 2016:
|  | March 31, 2017 |  |  | March 31, 2016 |
Operating revenues |  | $ | 9,809,997 |  |  | $ | 3,954,797 |
Operating expenses: |  |  |  |  |  |  |  |
Cost of sales |  |  | 10,090,073 |  |  |  | 3,611,024 |
General and administrative |  |  | 2,876,132 |  |  |  | 1,218,564 |
Research and development |  |  | 1,042,496 |  |  |  | 777,942 |
Depreciation, amortization and impairment |  |  | 1,738,819 |  |  |  | 313,893 |
|  |  | 15,747,520 |  |  |  | 5,921,423 |
Operating loss |  |  | (5,937,523 | ) |  |  | (1,966,626 | )
Non-operating expense, net |  |  | (361,098 | ) |  |  | (21,111 | )
Loss before income taxes |  |  | (6,298,621 | ) |  |  | (1,987,737 | )
Income taxes |  |  | - |  |  |  | - |
Net loss |  | $ | (6,298,621 | ) |  | $ | (1,987,737 | )
Non-operating expense, net, includes intercompany interest expense of approximately $424,000 associated with the Senior Subordinated Note and the Delphax Senior Credit Agreement for the fiscal year ended March 31, 2017 and approximately $76,000 for the fiscal year ended March 31, 2016. This interest expense was eliminated for purposes of net income (loss) presented in the Company ’s accompanying consolidated statements of income (loss) and comprehensive income (loss) for the years ended March 31, 2017 and 2016, though the effect of intercompany interest expense under the Senior Subordinated Note and the Delphax Senior Credit Agreement is reflected in the attribution of Delphax net income or losses attributed to non-controlling interests. As disclosed in the Company ’s Form 10 -Q for the quarter ended June 30, 2016, Delphax was informed by its largest customer that the customer had decided to accelerate its plans for removing Delphax legacy printing systems from production and that Delphax should, as a consequence, expect the future volume of legacy product orders from the customer to decline markedly from prior forecasts. Furthermore, the future timeframe over which orders could be expected from this customer was being sharply curtailed. In addition to this specific customer communication, Delphax also experienced a broad-based decline in legacy product customer demand during the first quarter. Sales of Delphax’s new élan printer system also had not materialized to expectations. The adverse business developments during the quarter ended June 30, 2016 and the significantly deteriorated outlook for future orders of legacy and élan product caused the Company to reevaluate the recoverability of Delphax ’s assets, both tangible and intangible. Based on this reevaluation, which involved material estimation and subjectivity (including with respect to the recovery on assets in an operating liquidation), the Company concluded that a significant increase to inventory reserves was necessary. In addition, the Company concluded that Delphax related intangible assets, both amortizable assets and goodwill, should be fully impaired. The Company also recorded a partial impairment of Delphax related long-lived tangible assets. Furthermore, there was an assessment regarding whether, at June 30, 2016, future severance actions under existing Delphax employee benefit plans were both probable and estimable. This assessment led to the Company establishing an estimated accrual for future severance actions. The effects of these various adjustments, which aggregated to approximately $5,610,000, were reflected in the operating results of Delphax for the quarter ended June 30, 2016. There were no significant additions to inventory and severance reserves from June 30, 2016 to March 31, 2017. The Company concluded that Delphax related intangible assets, both amortizable assets and goodwill, should be fully impaired. The Company recorded goodwill of approximately $375,000 in connection with its investment in Delphax. The Company estimated a subsequent impairment of this goodwill during the fiscal year ended March 31, 2016 of $100,000 and an additional impairment of $275,000 during the quarter ended June 30, 2016. These impairment losses are reflected on the consolidated statement of income (loss) within the “depreciation, amortization and impairment” line item. Intangible assets of Delphax had a net book value of approximately $1.4 million as of March 31, 2016. During the quarter ended June 30, 2016, the Company recognized an impairment charge which resulted in the remaining net book of Delphax intangible assets being fully written off. The Company estimated and recorded a tradename and patent impairment charge related to Delphax in the amount of approximately $1,385,000 during the quarter ended June 30, 2016. An impairment charge in the amount of $50,000 was recorded during the fiscal year 2016. These impairment losses are reflected on the consolidated statement of income (loss) within the “depreciation, amortization and impairment” line item. The above described adverse business developments drove significant negative operating results and led to severe liquidity constraints for Delphax. In addition to other measures intended to respond to developments, Delphax engaged an outside advisory firm to assist with operations, cost reductions and expense rationalization, and to provide an objective assessment and recommendations regarding Delphax ’s business outlook and alternative courses of action. During the quarter ended June 30, 2016, a number of Delphax employees were either severed or furloughed. For most of fiscal year 2017, Delphax’s operations have been maintained at a significantly curtailed level. We determined that the attribution of Delphax net income or loss should be based on consideration of all of Air T ’s investments in Delphax and Delphax Canada. As disclosed in Note 8, the Warrant provides that in the event that dividends are paid on the common stock of Delphax, the holder of the Warrant is entitled to participate in such dividends on a ratable basis as if the Warrant had been fully exercised and the shares of Series B Preferred Stock acquired upon such exercise had been converted into shares of Delphax common stock. This provision would have entitled Air T, Inc. to approximately 67% of any Delphax dividends paid, with the remaining 33% paid to the non-controlling interests. We concluded that this was a substantive distribution right which should be considered in the attribution of Delphax net income or loss to non-controlling interests. We furthermore concluded that our investment in the debt of Delphax should be considered in attribution. Specifically, Delphax ’s net losses are attributed first to our Series B Preferred Stock and Warrant investments and to the non-controlling interest ( 67%/33% ) until such amounts are reduced to zero. Additional losses are then fully attributed to our debt investments until they too are reduced to zero. This sequencing reflects the relative priority of debt to equity. Any further losses are then attributed to Air T and the non-controlling interests based on the initial 67%/33% share. Delphax net income is attributed using a backwards-tracing approach with respect to previous losses. The effect of interest expense arising under the Senior Subordinated Note and, since January 6, 2017, under the Delphax Senior Credit Agreement, and other intercompany transactions, are reflected in the attribution of Delphax net losses attributed to non-controlling interests because Delphax is a VIE. As a result of the application of the above-described attribution methodology, for the fiscal years ended March 31, 2017 and 2016, the attribution of Delphax losses to non-controlling interests was 30% and 33%, respectively.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -URI http://asc.fasb.org/topic&trid=2197479 + Details
Name: | us-gaap_VariableInterestEntityDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration